The experimental Ebola vaccine dubbed cAd3-EBO triggered positive immune response in its first clinical trial involving 20 adults. Two of the volunteers had fever after vaccination, but no serious side effects were reported.
The experimental Ebola vaccine dubbed cAd3-EBO triggered positive immune response in its first clinical trial involving 20 adults. Two of the volunteers had fever after vaccination, but no serious side effects were reported.
Share this Article
Recommended